Constitutive_JJ
activation_NN
of_IN
an_DT
epithelial_JJ
signal_NN
transducer_NN
and_CC
activator_NN
of_IN
transcription_NN
-LRB-_-LRB-
STAT_NN
-RRB-_-RRB-
pathway_NN
in_IN
asthma_NN
._.

Cytokine_NN
effects_NNS
on_IN
immunity_NN
and_CC
inflammation_NN
often_RB
depend_VBP
on_IN
the_DT
transcription_NN
factors_NNS
termed_VBN
signal_NN
transducers_NNS
and_CC
activators_NNS
of_IN
transcription_NN
-LRB-_-LRB-
STATs_NNS
-RRB-_-RRB-
,_,
so_IN
STAT_NN
signaling_NN
pathways_NNS
are_VBP
candidates_JJ
for_IN
influencing_VBG
inflammatory_JJ
disease_NN
._.

We_PRP
reasoned_VBD
that_IN
selective_JJ
IFN_NN
responsiveness_NN
of_IN
the_DT
first_JJ
STAT_NN
family_NN
member_NN
-LRB-_-LRB-
Stat1_NN
-RRB-_-RRB-
and_CC
Stat1-dependent_JJ
immune-response_JJ
genes_NNS
such_JJ
as_IN
intercellular_JJ
adhesion_NN
molecule-1_NN
-LRB-_-LRB-
ICAM-1_NN
-RRB-_-RRB-
,_,
IFN_NN
regulatory_JJ
factor-1_NN
-LRB-_-LRB-
IRF-1_NN
-RRB-_-RRB-
,_,
and_CC
Stat1_NN
itself_NN
in_IN
airway_NN
epithelial_JJ
cells_NNS
provides_VBZ
a_DT
basis_NN
for_IN
detecting_VBG
cytokine_NN
signaling_NN
abnormalities_NNS
in_IN
inflammatory_JJ
airway_NN
disease_NN
._.

On_IN
the_DT
basis_NN
of_IN
nuclear_JJ
localization_NN
and_CC
phosphorylation_NN
,_,
we_PRP
found_VBD
that_IN
epithelial_JJ
Stat1_NN
-LRB-_-LRB-
but_CC
not_RB
other_JJ
control_NN
transcription_NN
factors_NNS
-RRB-_-RRB-
was_VBD
invariably_RB
activated_VBN
in_IN
asthmatic_JJ
compared_VBN
with_IN
normal_JJ
control_NN
or_CC
chronic_JJ
bronchitis_NN
subjects_NNS
._.

Furthermore_RB
,_,
epithelial_JJ
levels_NNS
of_IN
activated_VBN
Stat1_NN
correlated_VBN
with_IN
levels_NNS
of_IN
expression_NN
for_IN
epithelial_JJ
ICAM-1_NN
,_,
IRF-1_NN
,_,
and_CC
Stat1_NN
,_,
and_CC
in_IN
turn_NN
,_,
ICAM-1_NN
levels_NNS
correlated_VBD
with_IN
T-cell_NN
accumulation_NN
in_IN
tissue_NN
._.

However_RB
,_,
only_RB
low_JJ
levels_NNS
of_IN
IFN-gamma_NN
or_CC
IFN-gamma-producing_JJ
cells_NNS
were_VBD
detected_VBN
in_IN
airway_NN
tissue_NN
in_IN
all_DT
subjects_NNS
._.

The_DT
results_NNS
therefore_RB
provide_VBP
initial_JJ
evidence_NN
linking_VBG
abnormal_JJ
behavior_NN
of_IN
STAT_NN
pathways_NNS
for_IN
cytokine_NN
signaling_NN
to_TO
the_DT
development_NN
of_IN
an_DT
inflammatory_JJ
disease_NN
._.

In_IN
that_DT
context_NN
,_,
the_DT
results_NNS
also_RB
change_VBP
the_DT
current_JJ
scheme_NN
for_IN
asthma_NN
pathogenesis_NN
to_TO
one_CD
that_WDT
must_MD
include_VB
a_DT
localized_JJ
gain_NN
in_IN
transcriptional_JJ
signal_NN
ordinarily_RB
used_VBN
for_IN
a_DT
T_NN
helper_NN
1-type_JJ
cytokine_NN
-LRB-_-LRB-
IFN-gamma_NN
-RRB-_-RRB-
in_IN
combination_NN
with_IN
allergy-driven_JJ
overproduction_NN
of_IN
T_NN
helper_NN
2-type_JJ
cytokines_NNS
._.

